Cultivation of Neisseria gonorrhoeae in liquid media and determination of its in vitro susceptibilities to quinolones

Journal of Clinical Microbiology

Volumn 43, Issue 9, 2005, Pages 4321-4327

  Takei, Masaya ^a,b   Yamaguchi, Yuko ^b   Fukuda, Hideyuki ^b   Yasuda, Mitsuru ^a   Deguchi, Takashi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; QUINOLONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; GROWTH REGULATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; NEISSERIA GONORRHOEAE; QUINOLONES;

NEISSERIA GONORRHOEAE;

EID: 24744441027     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.9.4321-4327.2005     Document Type: Article

References (27)

1. Berrón, S., J. A. Vázquez, M. J. Giménez, L. de la Fuente, and L. Aguilar. 2000. In vitro susceptibilities of 400 Spanish isolates of Neisseria gonorrhaeae to gemifloxacin and 11 other antimicrobial agents. Antimicrob. Agents Chemother. 44:2543-2544.
2. Bowker, K. E., M. Wootton, C. A. Rogers, R. Lewis, H. A. Holt, and A. P. MacGowan. 1999. Comparison of in-vitro pharmacodynamics of once and twice daily ciprofloxacin. J. Antimicrob. Chemother. 44:661-667.
3. Cartwright, C. P., F. Stock, and V. J. Gill. 1994. Improved enrichment broth for cultivation of fastidious organisms. J. Clin. Microbiol. 32:1825-1826.
4. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, T. Ezaki, I. Saito, and Y. Kawada. 1996. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob. Agents Chemother. 40:1020-1023.
5. Deguchi, T., I. Saito, M. Tanaka, K. Sato, K. Deguchi, M. Yasuda, M. Nakano, Y. Nishino, E. Kanematsu, S. Ozeki, and Y. Kawada. 1997. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones. Sex. Transm. Dis. 24:247-250.
6. Ebisu, H., R. Kishii, M. Takei, and H. Fukuda. 2003. The effect of pharmacokinetic/pharmacodynamic (PK/PD) parameters of gatifloxacin on its bactericidal activity and resistance selectivity against clinical isolates of Streptococcus pneumoniae. J. Infect. Chemother. 9:210-214.
7. Geers, T. A., and A. M. Donabedian. 1989. Comparison of broth microdilution and agar dilution for susceptibility testing of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 33:233-234.
8. Gustafsson, I., E. Lowdin, I. Odenholt, and O. Cars. 2001. Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model. Antimicrob. Agents Chemother. 45:2436-2440.
9. Hendry, A. T. 1983. Growth responses of Neisseria gonorrhoeae auxotypes to required amino acids and bases in liquid medium. Can. J. Microbiol. 29:1309-1313.
10. Hosaka, M., T. Yasue, H. Fukuda, H. Tomizawa, H. Aoyama, and K. Hirai. 1992. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob. Agents Chemother. 36:2108-2117.
11. Ito, M., M. Yasuda, S. Yokoi, S. Ito, Y. Takahashi, S. Ishihara, S. Maeda, and T. Deguchi. 2004. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob. Agents Chemother. 48:3185-3187.
12. Iverson, C. J., S. A. Wang, M. V. Lee, R. G. Ohye, D. L. Trees, J. S. Knapp, P. V. Effler, N. P. O'Connor, and W. C. Levine. 2004. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000: role of foreign importation and increasing endemic spread. Sex. Transm. Dis. 31:702-708.
13. Jones, R. T., and R. S. Talley. 1977. Simplified complete medium for the growth of Neisseria gonorrhoeae. J. Clin. Microbiol. 5:9-14.
14. MacGowan, A., C. Rogers, H. A. Holt, M. Wootton, and K. Bowker. 2000. Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacin. J. Antimicrob. Chemother. 46:73-78.
15. MacGowan, A., C. Rogers, and K. Bowker. 2000. The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens. J. Antimicrob. Chemother. 46:163-170.
16. Madaras-Kelly, K. J., B. E. Ostergaard, L. B. Hovde, and J. C. Rotschafer. 1996. Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 40:627-632.
17. Matsumoto, F., H. Kobayashi, K. Takamura, and H. Takeda. 1985. Pharmacokinetics with BAY O 9867 (ciprofloxacin). Jpn. J. Chemother. 33:140-188.
18. Moran, J. S., and W. C. Levine. 1995. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin. Infect. Dis. 20:S47-S65.
19. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline. NCCLS M26-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
20. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard NCCLS M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. Norrod, E. P., and S. A. Morse. 1982. Presence of hydrogen peroxide in media used for cultivation of Neisseria gonorrhoeae. J. Clin. Microbiol. 15:103-108.
22. Shapiro, M. A., C. L. Heifetz, and J. C. Sesnie. 1984. Comparison of microdilution and agar dilution procedures for testing antibiotic susceptibility of Neisseria gonorrhoeae. J. Clin. Microbiol. 20:828-830.
23. Shockley, R. K., E. E. Coffee, and K. H. Johnston. 1980. SJ-GC, a modified complete medium for growth of Neisseria gonorrhoeae. J. Clin. Microbiol. 12:35-38.
24. Tanaka, M., H. Nakayama, T. Notomi, S. Irie, Y. Tsunoda, A. Okadome, T. Saika, and I. Kobayashi. 2004. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates. Int. J. Antimicrob. Agents 24:15-22.
25. Wong, T. P., R. K. Shockley, and K. H. Johnston. 1980. WSJM, a simple chemically defined medium for growth of Neisseria gonorrhoeae. J. Clin. Microbiol. 11:363-369.
26. Yasuda, M., H. Fukuda, S. Yokoi, S. Ishihara, Y. Kawada, and T. Deguchi. 2000. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV. J. Urol. 164:847-851.
27. Yong, D., T. S. Kim, J. R. Choi, J. H. Yum, K. Lee, Y. Chong, H. B. Oh, T. Shultz, and J. W. Tapsall. 2004. Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries. J. Antimicrob. Chemother. 54:451-455.